Compound Summary
hydroxyurea
Compound Information
hydroxyurea
Compound Name: | hydroxyurea |
Compound CID: | 3657 |
Synonyms: | hydroxyurea Hydroxycarbamide 127-07-1 N-Hydroxyurea 1-HYDROXYUREA More... |
Iupac Name: | hydroxyurea |
InChI: | InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4) |
InChIKey: | VSNHCAURESNICA-UHFFFAOYSA-N |
Canonical Smiles: | C(=O)(N)NO |
Isomeric Smiles: | C(=O)(N)NO |
Molecular Weight: | 76.055 |
Molecular Formula: | CH4N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
hydroxyurea
Molecular Weight: | 76.055 |
Molecular Formula: | CH4N2O2 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 5 |
Complexity: | 42.9 |
Synonyms
hydroxyurea
| hydroxyurea | hydroxyurea |
|---|---|
hydroxyurea |
Hydroxycarbamide |
127-07-1 |
N-Hydroxyurea |
1-HYDROXYUREA |
Hydrea |
Oxyurea |
Carbamoyl oxime |
Biosupressin |
Hydroxycarbamine |
Urea, hydroxy- |
Onco-carbide |
Carbamohydroxamic acid |
Carbamohydroximic acid |
Carbamyl hydroxamate |
Hydura |
Litalir |
Hydurea |
N-Carbamoylhydroxylamine |
Droxia |
Hidrix |
Hydroxicarbamidum |
Siklos |
Hydroxylurea |
Hydreia |
Litaler |
Idrossicarbamide DCIT |
Hidroxicarbamida |
Hydroxyharnstoff |
Hydroxycarbamidum |
Carbamohydroxyamic acid |
N-Hydroxymocovina |
Hydroxylamine, N-carbamoyl- |
SQ 1089 |
Hydroxyharnstoff German |
N-Hydroxymocovina Czech |
NCI-C04831 |
Hydroxylamine, N-(aminocarbonyl)- |
SK 22591 |
Hydroxycarbamidum INN-Latin |
Hidroxicarbamida INN-Spanish |
urea, N-hydroxy- |
HU |
CCRIS 958 |
HYDROXY-UREA |
NSC 32065 |
hydroxy urea |
UNII-X6Q56QN5QC |
NSC32065 |
AI3-51139 |
Hydroxyurea (Cytodrox) |
MFCD00007943 |
CHEMBL467 |
SQ-1089 |
X6Q56QN5QC |
CHEBI:44423 |
NSC-32065 |
NCGC00015520-03 |
Hydroxycarbamid |
Oncocarbide |
Idrossicarbamide |
DSSTox_CID_5438 |
DSSTox_RID_77787 |
DSSTox_GSID_25438 |
NHY |
Hydroxyurea (D4) |
N-HYDROXY UREA |
Mylocel |
carbamide oxide |
CAS-127-07-1 |
SMR000059149 |
Hydroxyurea (USP) |
Droxia (TM) |
Droxia (TN) |
Hydrea (TM) |
hydroxyaminomethanamide |
HSDB 6887 |
SR-01000075919 |
DRG-0253 |
EINECS 204-821-7 |
HYDREA (TN) |
Hydroxyurea USAN:USP |
BRN 1741548 |
Hydroxycarbamide (JAN/INN) |
hydroxyl urea |
Xromi |
S-phase/G-1 interface inhibitor |
aminohydroxamic acid |
carbamic acid oxime |
Carbomohydroxamic acid |
Spectrum_000909 |
Hydroxycarbamide INN |
WLN: ZVMQ |
Hydrea (Bristol Meyers) |
Spectrum2_000064 |
Spectrum3_000462 |
Spectrum4_000012 |
Spectrum5_000836 |
Lopac-H-8627 |
MolMap_000029 |
H 8627 |
NCIMech_000139 |
Hydroxyurea, 98%, powder |
ACMC-1C22W |
Lopac0_000596 |
BSPBio_002164 |
KBioGR_000383 |
KBioSS_001389 |
4-03-00-00170 (Beilstein Handbook Reference) |
8029-68-3 |
hydroxycarbamide (hydroxyurea) |
MLS001332381 |
MLS001332382 |
MLS002153389 |
DivK1c_000556 |
N-(Aminocarbonyl)hydroxylamine |
SPECTRUM1500344 |
SPBio_000247 |
GTPL6822 |
DTXSID6025438 |
tetratogen: inhibits ribonucleoside diphosphate reductase |
HMS501L18 |
KBio1_000556 |
KBio2_001389 |
KBio2_003957 |
KBio2_006525 |
KBio3_001384 |
NINDS_000556 |
Bio1_000451 |
Bio1_000940 |
Bio1_001429 |
HMS1920F09 |
HMS2091L17 |
HMS2234I03 |
HMS3261H14 |
HMS3373G18 |
HMS3655K20 |
HMS3869C03 |
NCI C04831 |
Pharmakon1600-01500344 |
ACT02611 |
ALBB-028465 |
AMY40858 |
EBD12517 |
HY-B0313 |
STR02555 |
ZINC8034120 |
Tox21_110168 |
Tox21_300319 |
Tox21_500596 |
BBL009928 |
BDBM50017811 |
CCG-35236 |
NSC757072 |
s1896 |
STL145898 |
AKOS005716276 |
AKOS006222547 |
Tox21_110168_1 |
ZINC100019199 |
DB01005 |
LP00596 |
MCULE-9465284053 |
NSC-757072 |
SDCCGSBI-0050578.P006 |
IDI1_000556 |
NCGC00015520-01 |
NCGC00015520-02 |
NCGC00015520-04 |
NCGC00015520-05 |
NCGC00015520-06 |
NCGC00015520-07 |
NCGC00015520-08 |
NCGC00015520-09 |
NCGC00015520-10 |
NCGC00015520-11 |
NCGC00015520-20 |
NCGC00093974-01 |
NCGC00093974-02 |
NCGC00093974-03 |
NCGC00093974-04 |
NCGC00093974-05 |
NCGC00254007-01 |
NCGC00261281-01 |
AC-22674 |
NCI60_002773 |
SBI-0050578.P004 |
AB0013265 |
DB-041849 |
EU-0100596 |
FT-0627160 |
FT-0627175 |
FT-0670210 |
H0310 |
SW218071-2 |
C07044 |
D00341 |
Hydroxyurea, Vetec(TM) reagent grade, >=98% |
AB00052018-09 |
AB00052018-10 |
AB00052018_11 |
AB00052018_12 |
127H071 |
A805636 |
Q212272 |
J-504798 |
SR-01000075919-1 |
SR-01000075919-3 |
SR-01000075919-8 |
E0723DBA-5AF3-49D1-B5F6-59420AB87AC9 |
F8880-0905 |
Z1522566612 |
Hydroxycarbamide, European Pharmacopoeia (EP) Reference Standard |
Hydroxyurea, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
hydroxyurea
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -1.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
hydroxyurea
Statistics Data
hydroxyurea
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -1.000000000000000 | 1 | 1 |
Statistics Data Visualization
hydroxyurea
